Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AKBA Akebia Therapeutics Inc

-0.02 (-1.71%)
Dec 08 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Akebia Therapeutics Inc AKBA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -1.71% 1.15 19:37:50
Open Price Low Price High Price Close Price Prev Close
1.17 1.12 1.175 1.13 1.17
more quote information »

Recent News

Date Time Source Heading
12/08/20236:10IHNWFeaturedFREEDOM HOLDINGS (FHLD) SHAREHOLDER UPDATE; Freedom, Holdings Inc symbol: FHLD 15C-211 nears final approval from FINRA
12/01/202316:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
11/21/202317:07EDGAR2Form 8-K - Current report
11/20/202308:00PRNUSAkebia Therapeutics to Present at Piper Sandler Healthcare..
11/08/202307:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202307:33EDGAR2Form 8-K - Current report
11/08/202307:30PRNUSAkebia Therapeutics Reports Third Quarter 2023 Financial..
11/02/202316:34EDGAR2Form 8-K - Current report
11/02/202316:30PRNUSAkebia Therapeutics Announces Favorable Payment Term..
11/01/202316:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
10/31/202308:00PRNUSAkebia Therapeutics to Report Third Quarter 2023 Financial..
10/25/202316:06EDGAR2Form 8-K - Current report
10/25/202308:30PRNUSAkebia Receives FDA Acceptance of Resubmission to NDA of..
10/18/202308:00PRNUSAkebia Therapeutics Announces Five Poster Presentations at..
10/12/202308:31EDGAR2Form 8-K - Current report
10/03/202316:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
9/28/202308:00PRNUSAkebia Therapeutics Resubmits New Drug Application to the..
9/26/202316:47EDGAR2Form 8-K - Current report
9/26/202308:00PRNUSAkebia Announces Approval of Vafseo® (vadadustat) in..
9/06/202308:00PRNUSAkebia Therapeutics to Present at H.C. Wainwright Global..
9/05/202316:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
8/28/202308:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/28/202308:55EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
8/25/202308:14EDGAR2Form 8-K - Current report
8/25/202308:09PRNUSAkebia Therapeutics Reports Second Quarter 2023 Financial..
8/24/202308:00PRNUSAkebia Therapeutics Expects to Resubmit Vadadustat NDA in..
8/23/202316:35PRNUSAkebia Therapeutics to Report Second Quarter Financial..
8/17/202316:09EDGAR2Form 8-K - Current report
8/17/202316:05PRNUSAkebia Therapeutics to Report Second Quarter Financial..
8/11/202307:35EDGAR2Form 8-K - Current report
8/10/202317:40PRNUSAkebia Therapeutics Provides Update on Form 10-Q Filing
8/10/202317:11EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
8/01/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/01/202316:30PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
8/01/202316:05EDGAR2Form 8-K - Current report
7/19/202307:45PRNUSAkebia Therapeutics to Present at the H.C. Wainwright Kidney..
7/18/202316:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
7/18/202307:47EDGAR2Form 8-K - Current report
7/18/202307:45PRNUSAkebia Therapeutics Completed Type A Meeting with the FDA..
7/05/202316:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
6/29/202308:00PRNUSAkebia Therapeutics Announces Positive Top-Line Results of..
6/20/202308:00PRNUSAkebia Announces Swissmedic Approval of Vafseo® (vadadustat)
6/13/202307:00PRNUSAkebia Therapeutics Announces New Chief Financial Officer
6/02/202308:30PRNUSAkebia Therapeutics to Present at Jefferies Healthcare..
6/01/202316:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
5/30/202307:30PRNUSFDA Provides Akebia Therapeutics a Path Forward for..
5/25/202308:00PRNUSAkebia Therapeutics Enters into License Agreement with..
5/22/202317:15PRNUSAkebia Therapeutics Regains Compliance with Nasdaq Minimum..
5/22/202308:30PRNUSAkebia Announces UK MHRA Approval of Vafseo® (vadadustat)..
5/08/202307:30PRNUSAkebia Therapeutics Reports First Quarter 2023 Financial..
5/01/202308:00PRNUSAkebia Therapeutics to Report First Quarter Financial..

Your Recent History

Delayed Upgrade Clock